StockTipsArenaBeta

BUY Aurobindo Pharma — Rajesh Palviya, Axis Securities

BUYAurobindo Pharma
Aurobindo Pharma share price target & all analyst calls

byRajesh Palviya, Axis SecuritiesHorizon: NA (inferred Swing (≤2wk))7 Apr 2026via CNBC Awaaz.

Entry₹1,352.1Inferred
Target₹1,400
Total upside +3.54% (call closed)
Stop loss₹1,315-2.74% risk
Exit₹1,40021 Apr 2026, 12:50 pm
Target hit+3.54%0.00%upside left
Follow Rajesh Palviya for new calls(27% target hit, 178 closed calls)Get alertsWatch AUROPHARMA for new buy/sell callsGet alertsSee 1 active Swing call on AUROPHARMASee 149 active Swing picks this week

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 25 Oct, 9:34 pm IST
1 supporting1 neutral0 opposing
Supports the BUY call (1)

2 advisors have active short-term BUY calls on this stock

Advisor consensus · adjacent horizon·6 Apr · 2w ago

Neutral / worth noting (1)

Upcoming Stock Split, Dividend, Bonus Issue THIS Week: Aurobindo Pharma, Muthoot Finance, More | Full List

NewsGoogle News·12 Apr · 1w ago

(opens in new tab)
Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

Other calls on Aurobindo Pharma

All analyst calls on Aurobindo Pharma

More from Rajesh Palviya, Axis Securities

Every call and its outcome